Blueprint Medicines Co. (NASDAQ:BPMC) CFO Sells $1,050,000.00 in Stock

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) CFO Michael Landsittel sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $105.00, for a total value of $1,050,000.00. Following the transaction, the chief financial officer now owns 47,286 shares of […]

Related Keywords

United States ,Michael Landsittel ,Blueprint Medicines Company Profile ,Polar Capital Holdings Plc ,Nasdaq ,Blueprint Medicines Co ,Norges Bank ,Goldman Sachs Group ,Needham Company ,Citigroup ,Blueprint Medicines Corporation ,Blueprint Medicines ,Get Free Report ,Medicines Stock Down ,Capital Holdings Plc ,Springs Capital Management ,Partners Management ,Medicines Corporation ,Blueprint Medicines Daily ,Nasdaq Bpmc ,Bpmc ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,